Sustainability - Our ESG Framework
Building a kidney-care company that lasts a generation.
Patients on our medicines will be patients for decades. They deserve a supplier they can rely on for decades too. Our ESG posture is the institutional discipline that makes that possible.
The framework
Three pillars. One company.
Our framework follows the structure used by globally-recognised pharmaceutical companies - adapted to our scale and stage.
01
Healthy Patients & Communities
- • Access to essential nephrology medicines
- • Affordability initiatives
- • Product quality and patient safety
- • Community investment (linked to CSR)
02
Healthy Planet
- • Carbon footprint baseline (Scope 1, 2, eventually 3)
- • Water stewardship at partner manufacturing sites
- • Waste reduction and circular packaging
- • Responsible sourcing
03
Healthy Vyapitus
- • Workforce: D&I, wellbeing, learning
- • Business ethics and anti-bribery
- • Data privacy and cybersecurity
- • Product safety oversight and product quality
Environment
Where we measure first.
As an organisation built around partner manufacturing, our direct Scope 1 footprint is modest, but our Scope 2 (purchased electricity) and especially Scope 3 (supply chain, distribution, employee travel) emissions are material.
We are in the process of establishing our environmental baseline. Once measured, targets will follow. Disclosures will be made in our first ESG / Sustainability Report.
Reporting roadmap
- •FY26: Baseline measurement across Scope 1 & 2.
- •FY26–27: First ESG / Sustainability Report.
- •FY27 onwards: BRSR-aligned disclosure (post-listing) and Scope 3 expansion.
Social
People, safety, communities.
Our workforce
Field force, medical affairs, supply chain, quality, regulatory, corporate functions. We invest in structured learning and development with a focus on nephrology and transplant medicine.
Diversity, equity & inclusion
We aim for diverse hiring across functions and seniority levels and report transparently on workforce composition once the workforce reaches the scale at which the metric is meaningful.
Anti-harassment
A formal POSH (Prevention of Sexual Harassment) policy is in place. The Internal Committee composition and reporting channels are detailed in the policy document.
Governance
The plumbing that makes the rest credible.
Business ethics & anti-bribery
Our Code of Conduct, Anti-Bribery & Anti-Corruption Policy and Whistle-blower mechanism govern how we work. All policies will be published in the Investors section.
Data privacy & cybersecurity
A DPDP-Act-2023 compliant privacy posture, a hardened web architecture, and breach-response procedures align with our commitment to keep patient and partner data safe.
Coming soon
ESG Baseline Report - FY26
Our first formal ESG report will be published at the close of FY26 and will be downloadable from this page. It will set out our environmental baseline, social metrics and governance posture in detail.